Navigation auf uzh.ch
Navigation auf uzh.ch
Persisting neuropsychiatric symptoms, Alzheimer's disease and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate Ouanes, S, Rabl M, Clark C, Kirschbaum C, Popp J (2022).. Alz Res Therapy, 2022, 14, 19DOI: 10.1186/s13195-022-01139-9
Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people, Rabl M, Clark C, Dayon L, Bowman G, Popp J, J Neurochemistry 2022, 00, 1– 13 DOI: 10.1111/jnc.15715
Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people. Clark C, Richiardi, J, Maréchal B, Bowman G, Dayon L, Popp J. J Neuroinflammation 2022, 19, 127, DOI: 10.1186/s12974-022-02473-3
Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer's Disease, Mroczek M, Clark C, Dayon L, Bowman G, Popp J; DOI: 10.3390/cells11061030
An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease Clark C, Dayon L, Masoodi M, Bowman GL, Popp J. Alzheimers Res Ther. 2021 Apr 1;13(1):71. DOI: 10.1186/s13195-021-00814-7
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression. Clark C, Lewczuk P, Kornhuber J, Richiardi J, Maréchal B, Karikari TK, Blennow K, Zetterberg H, Popp J. Alzheimers Res Ther. 2021 Mar 25;13(1):65 DOI: 10.1186/s13195-021-00805-8
Factors associated with subjective cognitive decline in dementia-free older adults-A population-based study. Zullo L, Clark C, Gholam M, Castelao E, von Gunten A, Preisig M, Popp J. Int J Geriatr Psychiatry. 2021 Feb 8. DOI: 10.1002/gps.5509
Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression. Jahn T, Clark C, Kerksiek A, Lewczuk P, Lütjohann D, Popp J. J Steroid Biochem Mol Biol. 2021 Jan;205:105785. DOI: 10.1016/j.jsbmb.2020.105785
Systemic and central nervous system metabolic alterations in Alzheimer’s disease. van der Velpen V, Teav T, Gallart-Ayala H, Mehl F, Konz I, Clark C, Oikonomidi A, Peyratout G, Henry H, Mauro Delorenzi M, Ivanisevic J*, Popp J*. Alzheimers Res Ther. 2019 Nov 28;11(1):93 *Popp and Ivanisevic: equal contribution DOI: 10.1186/s13195-019-0551-7
Blood-brain barrier breakdown, neuroinflammation and cognitive decline in older adults. Bowman GM, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin I, Henry H, Oikonomidi A, Migliavacca E, Bacher M, Popp J. Alzheimer's & Dementia. 2018 Dec;14(12):1640-1650. DOI: 10.1016/j.jalz.2018.06.2857
